Table 2 Correlation between butyric acid in serum and clinicopathological parameters
Factor | Butyric acid high | Butyric acid low | P value | ||
---|---|---|---|---|---|
NO. | % | NO. | % | ||
All patients | 28 | 49.1 | 29 | 50.9 | |
Age, years | 0.5 | ||||
≤54 | 13 | 48.4 | 17 | 51.6 | |
>54 | 15 | 50 | 12 | 50 | |
Tumor size, cm | 0.7 | ||||
≤1 | 13 | 44.8 | 16 | 55.2 | |
>1 | 15 | 53.6 | 13 | 46.4 | |
Node status | 1 | ||||
Negative | 9 | 50 | 9 | 50 | |
Positive | 19 | 48.7 | 20 | 51.3 | |
Distant metastasis | 0.02 | ||||
Negative | 21 | 63.6 | 12 | 36.4 | |
Positive | 7 | 29.2 | 17 | 70.8 | |
Stage | 0.02 | ||||
I or II | 21 | 63.6 | 12 | 36.4 | |
III | 7 | 29.2 | 17 | 70.8 | |
ER status | 1 | ||||
Negative | 6 | 60 | 4 | 40 | |
Positive | 22 | 46.8 | 25 | 53.2 | |
PR status | 1 | ||||
Negative | 5 | 45.5 | 6 | 54.5 | |
Positive | 22 | 48.9 | 23 | 51.1 | |
Missing | 1 | ||||
HER2 status | 1 | ||||
Negative | 3 | 42.9 | 4 | 57.1 | |
Positive | 23 | 47.9 | 25 | 52.1 | |
Missing | 2 | ||||
Ki67 status | 1 | ||||
≤0.3 | 15 | 53.6 | 13 | 46.4 | |
>0.3 | 10 | 50 | 10 | 50 | |
Missing | 3 | 6 | |||
CA153, U/mL | <0.0001 | ||||
≤9.48 | 21 | 72.4 | 8 | 27.6 | |
>9.48 | 7 | 25 | 21 | 75 |